Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2019 Filed Mar 5, 2019 01:03 UTC |
BONNEY MICHAEL WDirector
|
GrantStock option (right to buy) · Derivative | 3,213 | $0.00 Strike: $145.48 | $0.00 |
DisclosureSEC source: 0001209191-19-016030 · doc4.xml · derivative · entry 2 BONNEY MICHAEL W · CIK 0001219016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,213 Underlying: Common Stock · 3,213 shares Expires 2029-03-04 F2 · derivative.exercise_date: The option will vest at a rate of 1/24th of the total option amount granted on a monthly basis over two years commencing on the first monthly anniversary of the Issuer's 2019 Annual Meeting of Stockholders. Read SEC document |
| March 04, 2019 Filed Mar 5, 2019 01:03 UTC |
BONNEY MICHAEL WDirector
|
GrantCommon Stock | 1,633 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016030 · doc4.xml · nonDerivative · entry 1 BONNEY MICHAEL W · CIK 0001219016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,051 F1 · shares: Each restricted stock unit represents the right to receive one share of common stock and will vest in full on the first year anniversary of the Issuer's 2019 Annual Meeting of Stockholders. Read SEC document |
| March 04, 2019 Filed Mar 5, 2019 01:01 UTC |
Barry RichardDirector
|
GrantStock option (right to buy) · Derivative | 3,213 | $0.00 Strike: $145.48 | $0.00 |
DisclosureSEC source: 0001209191-19-016028 · doc4.xml · derivative · entry 2 Barry Richard · CIK 0001562371 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,213 Underlying: Common Stock · 3,213 shares Expires 2029-03-04 F2 · derivative.exercise_date: The option will vest at a rate of 1/24th of the total option amount granted on a monthly basis over two years commencing on the first monthly anniversary of the Issuer's 2019 Annual Meeting of Stockholders. Read SEC document |
| March 04, 2019 Filed Mar 5, 2019 01:01 UTC |
Barry RichardDirector
|
GrantCommon Stock | 1,633 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016028 · doc4.xml · nonDerivative · entry 1 Barry Richard · CIK 0001562371 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,172,065 F1 · shares: Each restricted stock unit represents the right to receive one share of common stock and will vest in full on the first year anniversary of the Issuer's 2019 Annual Meeting of Stockholders. Read SEC document |
| March 04, 2019 Filed Mar 5, 2019 01:02 UTC |
BEHRENS M KATHLEENDirector
|
GrantStock option (right to buy) · Derivative | 3,213 | $0.00 Strike: $145.48 | $0.00 |
DisclosureSEC source: 0001209191-19-016029 · doc4.xml · derivative · entry 3 BEHRENS M KATHLEEN · CIK 0001211701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,213 Underlying: Common Stock · 3,213 shares Expires 2029-03-04 F2 · derivative.exercise_date: The option will vest at a rate of 1/24th of the total option amount granted on a monthly basis over two years commencing on the first monthly anniversary of the Issuer's 2019 Annual Meeting of Stockholders. Read SEC document |
| March 04, 2019 Filed Mar 5, 2019 01:02 UTC |
BEHRENS M KATHLEENDirector
|
GrantCommon Stock | 1,633 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016029 · doc4.xml · nonDerivative · entry 1 BEHRENS M KATHLEEN · CIK 0001211701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,167 F1 · shares: Each restricted stock unit represents the right to receive one share of common stock and will vest in full on the first year anniversary of the Issuer's 2019 Annual Meeting of Stockholders. Read SEC document |
| February 28, 2019 Filed Mar 5, 2019 01:08 UTC |
Mahatme SandeshEVP, CFO & CBO
|
Disposition to issuerCommon Stock | 4,781 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016041 · doc4.xml · nonDerivative · entry 1 Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,868 F1 · shares: Forfeiture of 4,781 shares of restricted stock due to performance goal not met. Read SEC document |
| February 28, 2019 Filed Mar 5, 2019 01:07 UTC |
Howton David TEVP, General Counsel
|
Disposition to issuerCommon Stock | 3,825 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016040 · doc4.xml · nonDerivative · entry 1 Howton David T · CIK 0001529297 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,746 F1 · shares: Forfeiture of 3,825 shares of restricted stock due to performance goal not met. Read SEC document |
| February 28, 2019 Filed Mar 5, 2019 01:06 UTC |
Cumbo AlexanderEVP, Chief Commercial Officer
|
Disposition to issuerCommon Stock | 3,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016038 · doc4.xml · nonDerivative · entry 1 Cumbo Alexander · CIK 0001685994 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,450 F1 · shares: Forfeiture of 3,375 shares of restricted stock due to performance goal not met. Read SEC document |
| February 07, 2019 Filed Feb 9, 2019 01:02 UTC |
Mahatme SandeshEVP, CFO & CBO
|
Exercise / conversionStock Option (right to buy) · Derivative | 65,000 | $0.00 Strike: $23.85 | $0.00 |
DisclosureSEC source: 0001209191-19-008776 · doc4.xml · derivative · entry 4 Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,466 Underlying: Common Stock · 65,000 shares Expires 2022-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on October 29, 2018. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| February 07, 2019 Filed Feb 9, 2019 01:02 UTC |
Mahatme SandeshEVP, CFO & CBO
|
SaleCommon Stock | 65,000 | $145.00 | $9,425,000.00 |
DisclosureSEC source: 0001209191-19-008776 · doc4.xml · nonDerivative · entry 2 Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,649 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on October 29, 2018. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| February 07, 2019 Filed Feb 9, 2019 01:02 UTC |
Mahatme SandeshEVP, CFO & CBO
|
Exercise / conversionCommon Stock | 65,000 | $23.85 | $1,550,250.00 |
DisclosureSEC source: 0001209191-19-008776 · doc4.xml · nonDerivative · entry 1 Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,649 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on October 29, 2018. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| February 01, 2019 Filed Feb 2, 2019 01:27 UTC |
Cumbo AlexanderSVP, Chief Commercial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,250 | $0.00 Strike: $26.24 | $0.00 |
DisclosureSEC source: 0001209191-19-006634 · doc4.xml · derivative · entry 5 Cumbo Alexander · CIK 0001685994 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,965 Underlying: Common Stock · 5,250 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| February 01, 2019 Filed Feb 2, 2019 01:27 UTC |
Cumbo AlexanderSVP, Chief Commercial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,250 | $0.00 Strike: $13.90 | $0.00 |
DisclosureSEC source: 0001209191-19-006634 · doc4.xml · derivative · entry 4 Cumbo Alexander · CIK 0001685994 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,250 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| February 01, 2019 Filed Feb 2, 2019 01:27 UTC |
Cumbo AlexanderSVP, Chief Commercial Officer
|
SaleCommon Stock | 15,000 | $140.00 | $2,100,000.00 |
DisclosureSEC source: 0001209191-19-006634 · doc4.xml · nonDerivative · entry 3 Cumbo Alexander · CIK 0001685994 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,266 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| February 01, 2019 Filed Feb 2, 2019 01:27 UTC |
Cumbo AlexanderSVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 5,250 | $26.24 | $137,760.00 |
DisclosureSEC source: 0001209191-19-006634 · doc4.xml · nonDerivative · entry 2 Cumbo Alexander · CIK 0001685994 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| February 01, 2019 Filed Feb 2, 2019 01:27 UTC |
Cumbo AlexanderSVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 2,250 | $13.90 | $31,275.00 |
DisclosureSEC source: 0001209191-19-006634 · doc4.xml · nonDerivative · entry 1 Cumbo Alexander · CIK 0001685994 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| February 01, 2019 Filed Feb 2, 2019 01:25 UTC |
Howton David TSVP, General Counsel
|
Exercise / conversionStock Option (right to buy) · Derivative | 16,827 | $23.85 Strike: $23.85 | $401,323.95 |
DisclosureSEC source: 0001209191-19-006630 · doc4.xml · derivative · entry 7 Howton David T · CIK 0001529297 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,405 Underlying: Common Stock · 16,827 shares Expires 2022-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| February 01, 2019 Filed Feb 2, 2019 01:25 UTC |
Howton David TSVP, General Counsel
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,548 | $13.71 Strike: $13.71 | $21,223.08 |
DisclosureSEC source: 0001209191-19-006630 · doc4.xml · derivative · entry 6 Howton David T · CIK 0001529297 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,883 Underlying: Common Stock · 1,548 shares Expires 2025-09-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| February 01, 2019 Filed Feb 2, 2019 01:25 UTC |
Howton David TSVP, General Counsel
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,125 | $13.71 Strike: $13.71 | $42,843.75 |
DisclosureSEC source: 0001209191-19-006630 · doc4.xml · derivative · entry 5 Howton David T · CIK 0001529297 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,965 Underlying: Common Stock · 3,125 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| February 01, 2019 Filed Feb 2, 2019 01:25 UTC |
Howton David TSVP, General Counsel
|
SaleCommon Stock | 30,000 | $140.00 | $4,200,000.00 |
DisclosureSEC source: 0001209191-19-006630 · doc4.xml · nonDerivative · entry 4 Howton David T · CIK 0001529297 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,571 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| February 01, 2019 Filed Feb 2, 2019 01:25 UTC |
Howton David TSVP, General Counsel
|
Exercise / conversionCommon Stock | 16,827 | $23.85 | $401,323.95 |
DisclosureSEC source: 0001209191-19-006630 · doc4.xml · nonDerivative · entry 3 Howton David T · CIK 0001529297 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| February 01, 2019 Filed Feb 2, 2019 01:25 UTC |
Howton David TSVP, General Counsel
|
Exercise / conversionCommon Stock | 1,548 | $13.71 | $21,223.08 |
DisclosureSEC source: 0001209191-19-006630 · doc4.xml · nonDerivative · entry 2 Howton David T · CIK 0001529297 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| February 01, 2019 Filed Feb 2, 2019 01:25 UTC |
Howton David TSVP, General Counsel
|
Exercise / conversionCommon Stock | 3,125 | $13.71 | $42,843.75 |
DisclosureSEC source: 0001209191-19-006630 · doc4.xml · nonDerivative · entry 1 Howton David T · CIK 0001529297 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,196 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| January 31, 2019 Filed Feb 2, 2019 01:24 UTC |
Mahatme SandeshEVP, CFO & CBO
|
Exercise / conversionStock Option (right to buy) · Derivative | 21,198 | $0.00 Strike: $23.85 | $0.00 |
DisclosureSEC source: 0001209191-19-006627 · doc4.xml · derivative · entry 13 Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,466 Underlying: Common Stock · 21,198 shares Expires 2022-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| January 31, 2019 Filed Feb 2, 2019 01:24 UTC |
Mahatme SandeshEVP, CFO & CBO
|
SaleCommon Stock | 21,198 | $130.72 | $2,771,002.56 |
DisclosureSEC source: 0001209191-19-006627 · doc4.xml · nonDerivative · entry 7 Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,649 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| January 31, 2019 Filed Feb 2, 2019 01:24 UTC |
Mahatme SandeshEVP, CFO & CBO
|
Exercise / conversionCommon Stock | 21,198 | $23.85 | $505,572.30 |
DisclosureSEC source: 0001209191-19-006627 · doc4.xml · nonDerivative · entry 6 Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| January 30, 2019 Filed Feb 2, 2019 01:24 UTC |
Mahatme SandeshEVP, CFO & CBO
|
Exercise / conversionStock Option (right to buy) · Derivative | 19,345 | $0.00 Strike: $23.85 | $0.00 |
DisclosureSEC source: 0001209191-19-006627 · doc4.xml · derivative · entry 12 Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,664 Underlying: Common Stock · 19,345 shares Expires 2022-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| January 30, 2019 Filed Feb 2, 2019 01:24 UTC |
Mahatme SandeshEVP, CFO & CBO
|
Exercise / conversionStock Option (right to buy) · Derivative | 17,860 | $0.00 Strike: $13.90 | $0.00 |
DisclosureSEC source: 0001209191-19-006627 · doc4.xml · derivative · entry 11 Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,860 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| January 30, 2019 Filed Feb 2, 2019 01:24 UTC |
Mahatme SandeshEVP, CFO & CBO
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,128 | $0.00 Strike: $13.71 | $0.00 |
DisclosureSEC source: 0001209191-19-006627 · doc4.xml · derivative · entry 10 Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,771 Underlying: Common Stock · 1,128 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| January 30, 2019 Filed Feb 2, 2019 01:24 UTC |
Mahatme SandeshEVP, CFO & CBO
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,469 | $0.00 Strike: $13.71 | $0.00 |
DisclosureSEC source: 0001209191-19-006627 · doc4.xml · derivative · entry 9 Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,404 Underlying: Common Stock · 5,469 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| January 30, 2019 Filed Feb 2, 2019 01:24 UTC |
Mahatme SandeshEVP, CFO & CBO
|
SaleCommon Stock | 43,802 | $130.00 | $5,694,260.00 |
DisclosureSEC source: 0001209191-19-006627 · doc4.xml · nonDerivative · entry 5 Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,649 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| January 30, 2019 Filed Feb 2, 2019 01:24 UTC |
Mahatme SandeshEVP, CFO & CBO
|
Exercise / conversionCommon Stock | 19,345 | $23.85 | $461,378.25 |
DisclosureSEC source: 0001209191-19-006627 · doc4.xml · nonDerivative · entry 4 Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| January 30, 2019 Filed Feb 2, 2019 01:24 UTC |
Mahatme SandeshEVP, CFO & CBO
|
Exercise / conversionCommon Stock | 17,860 | $13.90 | $248,254.00 |
DisclosureSEC source: 0001209191-19-006627 · doc4.xml · nonDerivative · entry 3 Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| January 30, 2019 Filed Feb 2, 2019 01:24 UTC |
Mahatme SandeshEVP, CFO & CBO
|
Exercise / conversionCommon Stock | 1,128 | $13.71 | $15,464.88 |
DisclosureSEC source: 0001209191-19-006627 · doc4.xml · nonDerivative · entry 2 Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| January 30, 2019 Filed Feb 2, 2019 01:24 UTC |
Mahatme SandeshEVP, CFO & CBO
|
Exercise / conversionCommon Stock | 5,469 | $13.71 | $74,979.99 |
DisclosureSEC source: 0001209191-19-006627 · doc4.xml · nonDerivative · entry 1 Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,118 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Read SEC document |
| December 10, 2018 Filed Dec 11, 2018 13:38 UTC |
GRAY MARY ANNDirector
|
GrantRestricted Stock Units · Derivative | 2,901 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-061908 · doc4.xml · derivative · entry 2 GRAY MARY ANN · CIK 0001261974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,901 Underlying: Common Stock · 2,901 shares Expires 2028-12-10 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Sarepta Therapeutics, Inc. common stock. F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning December 10, 2019, subject to continued service to the Board. Read SEC document |
| December 10, 2018 Filed Dec 11, 2018 13:38 UTC |
GRAY MARY ANNDirector
|
GrantOption (right to buy) · Derivative | 5,711 | $0.00 Strike: $122.80 | $0.00 |
DisclosureSEC source: 0001209191-18-061908 · doc4.xml · derivative · entry 1 GRAY MARY ANN · CIK 0001261974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,711 Underlying: Common Stock · 5,711 shares Expires 2028-12-10 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning December 10, 2019, subject to continued service to the Board. Read SEC document |
| November 01, 2018 Filed Nov 2, 2018 22:01 UTC |
Wigzell Hans Lennart RudolfDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,667 | $0.00 Strike: $8.94 | $0.00 |
DisclosureSEC source: 0001209191-18-056987 · doc4.xml · derivative · entry 3 Wigzell Hans Lennart Rudolf · CIK 0001492766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,667 shares Expires 2020-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option to purchase shares is fully vested. Read SEC document |
| November 01, 2018 Filed Nov 2, 2018 22:01 UTC |
Wigzell Hans Lennart RudolfDirector
|
SaleCommon Stock | 6,667 | $140.50 | $936,713.50 |
DisclosureSEC source: 0001209191-18-056987 · doc4.xml · nonDerivative · entry 2 Wigzell Hans Lennart Rudolf · CIK 0001492766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,084 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $140.50 to $140.53, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the range set forth herein. Read SEC document |
| November 01, 2018 Filed Nov 2, 2018 22:01 UTC |
Wigzell Hans Lennart RudolfDirector
|
Exercise / conversionCommon Stock | 6,667 | $8.94 | $59,602.98 |
DisclosureSEC source: 0001209191-18-056987 · doc4.xml · nonDerivative · entry 1 Wigzell Hans Lennart Rudolf · CIK 0001492766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:00 UTC |
BEHRENS M KATHLEENDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $3.96 | $0.00 |
DisclosureSEC source: 0001209191-18-056986 · doc4.xml · derivative · entry 4 BEHRENS M KATHLEEN · CIK 0001211701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2019-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option to purchase shares is fully vested. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:00 UTC |
BEHRENS M KATHLEENDirector
|
SaleCommon Stock | 10,000 | $131.71 | $1,317,100.00 |
DisclosureSEC source: 0001209191-18-056986 · doc4.xml · nonDerivative · entry 2 BEHRENS M KATHLEEN · CIK 0001211701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,534 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $131.53 to $131.94, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the range set forth herein. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:00 UTC |
BEHRENS M KATHLEENDirector
|
Exercise / conversionCommon Stock | 10,000 | $3.96 | $39,600.00 |
DisclosureSEC source: 0001209191-18-056986 · doc4.xml · nonDerivative · entry 1 BEHRENS M KATHLEEN · CIK 0001211701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2018 Filed Oct 30, 2018 23:05 UTC |
INGRAM DOUGLAS SDirector · President & CEO
|
PurchaseCommon Stock | 3,134 | $120.94 | $379,025.96 |
DisclosureSEC source: 0001209191-18-056571 · doc4.xml · nonDerivative · entry 2 INGRAM DOUGLAS S · CIK 0001190644 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,945 F2 · price: The shares were purchased in multiple transactions at prices ranging from $120.81 to $121.00, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| October 30, 2018 Filed Oct 30, 2018 23:05 UTC |
INGRAM DOUGLAS SDirector · President & CEO
|
PurchaseCommon Stock | 13,561 | $120.26 | $1,630,845.86 |
DisclosureSEC source: 0001209191-18-056571 · doc4.xml · nonDerivative · entry 1 INGRAM DOUGLAS S · CIK 0001190644 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412,811 F1 · price: The shares were purchased in multiple transactions at prices ranging from $119.78 to $120.78, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| October 24, 2018 Filed Oct 26, 2018 22:43 UTC |
Mahatme SandeshEVP, CFO & CBO
|
Exercise / conversionStock Option (right to buy) · Derivative | 11,718 | $0.00 Strike: $13.71 | $0.00 |
DisclosureSEC source: 0001209191-18-056332 · doc4.xml · derivative · entry 11 Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,873 Underlying: Common Stock · 11,718 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan. F7 · derivative.exercise_date: The option vests based on time criteria (25% of the total option on 2/29/2017 and 1/48th of the total option in equal monthly installments thereafter). Read SEC document |
| October 24, 2018 Filed Oct 26, 2018 22:43 UTC |
Mahatme SandeshEVP, CFO & CBO
|
Exercise / conversionStock Option (right to buy) · Derivative | 29,080 | $0.00 Strike: $13.71 | $0.00 |
DisclosureSEC source: 0001209191-18-056332 · doc4.xml · derivative · entry 10 Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,899 Underlying: Common Stock · 29,080 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan. F6 · derivative.exercise_date: Half of the total options granted began vesting when the FDA provided marketing approval for eteplirsen on 9/19/2016 and the other half of the total options granted began vesting when Sarepta Therapeutics, Inc. filed a Marketing Authorization Application with the European Medicines Agency on 11/30/2016. Vesting of the options allocated to the achievement of each goal is as follows: (i) 50% of the options allocated to the achieved goal vested immediately upon achievement of the performance condition (25% of the total performance-based options granted) and (ii) the remaining 50% of the options allocated to the achieved goal (25% of the total performance-based options granted) vest over four years. 25% of the remaining options vested on the first year anniversary of the grant date, or 2/28/2017 and 1/48th of the remaining options vests monthly thereafter. Read SEC document |
| October 24, 2018 Filed Oct 26, 2018 22:43 UTC |
Mahatme SandeshEVP, CFO & CBO
|
Exercise / conversionStock Option (right to buy) · Derivative | 39,006 | $0.00 Strike: $13.90 | $0.00 |
DisclosureSEC source: 0001209191-18-056332 · doc4.xml · derivative · entry 9 Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,860 Underlying: Common Stock · 39,006 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan. F5 · derivative.exercise_date: The option vests based on time criteria (25% of the total option on 2/27/2016 and 1/48th of the total option in equal monthly installments thereafter). Read SEC document |
| October 24, 2018 Filed Oct 26, 2018 22:43 UTC |
Mahatme SandeshEVP, CFO & CBO
|
Exercise / conversionStock Option (right to buy) · Derivative | 9,596 | $0.00 Strike: $23.85 | $0.00 |
DisclosureSEC source: 0001209191-18-056332 · doc4.xml · derivative · entry 8 Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,009 Underlying: Common Stock · 9,596 shares Expires 2022-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option to purchase shares is fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.